Related Experiment Video

Updated: May 24, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

MicroRNA and its roles in esophageal cancer

Yu Fang1, Dianchun Fang, Jianguo Hu

  • 1Department of Cardiovascular and Thoracic Surgery, 2nd Xiangya Hospital, Central South University, Changsha, China.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|February 28, 2012
PubMed

Insights

MicroRNAs show promise as biomarkers for diagnosing esophageal cancer and predicting treatment success. Further research into microRNAs could lead to new strategies for preventing and treating this deadly cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Esophageal cancer is a leading cause of cancer mortality globally, with poor survival rates in advanced stages.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression, impacting cellular processes.
  • Current diagnostic and therapeutic strategies for esophageal cancer have limitations, necessitating novel approaches.

Purpose of the Study:

  • To explore the role of microRNAs as diagnostic and prognostic biomarkers for esophageal cancer.
  • To investigate the influence of microRNAs on esophageal cancer cell behavior and drug resistance.
  • To highlight the potential of microRNAs in developing new therapeutic strategies for esophageal cancer.

Main Methods:

  • Analysis of microRNA profiles in esophageal cancer tissues and serum.
  • Investigation of microRNA involvement in cellular proliferation, apoptosis, invasion, and metastasis.
  • Assessment of microRNA association with multi-drug resistance in esophageal cancer.

Main Results:

  • Specific microRNA profiles identified in cancerous tissues and serum can serve as diagnostic and prognostic markers.
  • MicroRNAs influence key biological behaviors of esophageal cancer cells, including proliferation and metastasis.
  • MicroRNAs are implicated in the multi-drug resistance of esophageal cancer.

Conclusions:

  • MicroRNAs hold significant potential as biomarkers for esophageal cancer diagnosis and prognosis.
  • Targeting microRNAs may offer novel therapeutic avenues for esophageal cancer treatment and overcoming drug resistance.
  • Further research into microRNA functions is crucial for advancing esophageal cancer prevention and therapy.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...